🚀 Project Ideas
Generating project ideas…
Summary
- Provides on‑demand human copy review and rewrite for health‑tech websites, eliminating AI‑generated “slop” and ensuring clear, compliant messaging.
- Core value: builds trust with patients and regulators by delivering medically accurate, human‑toned copy that converts.
Details
| Key |
Value |
| Target Audience |
Early‑stage health‑tech startups, telehealth providers, compounding pharmacies needing website/landing‑page copy. |
| Core Feature |
Human copywriter team (with medical background) edits AI drafts or writes from scratch, includes compliance check (FDA/FTC language) and quick turnaround (<48 h). |
| Tech Stack |
Web portal (React/NestJS), Stripe for payments, optional AI‑assisted first draft (LLM) + human editor queue, hosted on Vercel/AWS. |
| Difficulty |
Medium |
| Monetization |
Revenue-ready: subscription tier ($99/mo for up to 5 pages) or pay‑per‑page ($30/page). |
Notes
- HNers complained about “Claude‑ish” copy and wanted a human rewrite (didgeoridoo, lloydarmbrust). This service directly addresses that pain.
- Could spark discussion on balancing AI efficiency with human trust in medical messaging; practical utility for improving conversion and reducing compliance risk.
Summary
- Mobile/web app lets patients on GLP‑1 therapies log daily symptoms, side effects, weight, and blood‑work results, then sends structured dose‑adjustment requests to their clinician for approval.
- Core value: closes the feedback loop missing in current telehealth GLP services, enabling safe, personalized dose titration without rigid, one‑size‑fits‑all schedules.
Details
| Key |
Value |
| Target Audience |
Patients using semaglutide, tirzepatide, or other GLP‑1 agonists; clinicians who prescribe them. |
| Core Feature |
Symptom & outcome tracker, automated titration suggestions based on simple rules (e.g., increase if tolerance, decrease if GI side effects), secure messaging to doctor for approval, integrates with EHR via FHIR. |
| Tech Stack |
React Native (mobile) + Node.js/Express backend, PostgreSQL, Auth0 for auth, Twilio for notifications, optional HL7/FHIR server. |
| Difficulty |
Medium |
| Monetization |
Revenue-ready: B2B SaaS for clinics ($150/clinic/mo) + optional patient premium ($4.99/mo). |
Notes
- Commenters lamented inflexible telehealth processes and difficulty adjusting dose (colingauvin, anonymous391084). An app that lets patients request dose changes based on how they feel would be welcomed.
- Enables richer discussion on patient‑driven dosing, safety, and could become a foundation for outcomes‑based reimbursement models.
Summary
- A SaaS platform that coordinates prescriptions, inventory, and batch tracking between medical service organizations (MSOs) and compounding pharmacies, handling BAA/HIPAA docs, batch manifests, and regulatory compliance.
- Core value: reduces manual paperwork, ensures transparent, personalized compounding, and lets MSOs scale safely while maintaining control over the supply chain.
Details
| Key |
Value |
| Target Audience |
MSOs, telehealth brands, and compounding pharmacies that produce personalized GLP‑1, peptides, or HRT formulations. |
| Core Feature |
Prescription routing portal, real‑time batch status (API → compounding → fill‑finish → shipment), automated BAA/HIPAA document management, compliance checklist (USP <795>, state pharmacy board), analytics on yield and turnaround time. |
| Tech Stack |
Django (Python) + React UI, Postgres, Redis for queue, AWS S3 for document storage, DocuSign API for signatures, webhook telephony for SMS updates. |
| Difficulty |
High |
| Monetization |
Revenue-ready: tiered subscription ($500/mo base + $0.10 per prescription processed) or per‑batch fee. |
Notes
- HN users discussed credit‑card processing being solved via Stripe but highlighted complexity of legal front, manufacturing, and needing a “glue” that’s not hard (rootsudo). This SaaS provides that glue.
- Would generate practical utility by simplifying the MSO‑pharmacy workflow, potentially becoming a discussion point for scaling personalized meds while staying compliant.